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INTRODUCTION
Minimal Change Disease 
(MCD) is a common cause 
of nephrotic syndrome 
 accounting for up to 90% 
of nephrotic syndrome 
cases in children.1,2 How­
ever, it is much less com­
mon in adults, accounting 
for only 1–15% of cases 
which have a female 
 preponderance1 and are 
generally responsive to 
corticosteroids.3 Further­
more, the main risk factor 
for relapse as an adult  
is frequent relapses as  
a child.1
CASE DESCRIPTION
A 52­year­old male with a past medical 
history of biopsy confirmed MCD diagnosed 
at age 48 and paroxysmal atrial fibrillation 
and coronary artery disease presented to 
the hospital with abdominal pain, anasarca, 
and weight gain. Prior to admission and 
since his MCD diagnosis, he had failed 
multiple prednisone tapers and tacrolimus monotherapy with a total of  
2 significant flares before achieving remission with rituximab for the past 
year. During his new admission, he was diagnosed again with an MCD 
flare with a urine protein to creatinine ratio of 15.47 and placed on high 
dose corticosteroids. Despite steroid therapy, his renal function continued 
to decline, and he was subsequently restarted on rituximab. His hospital 
course was complicated by coagulopathy to an INR of 10.6 and 
hematemesis requiring transfer to the ICU where he was intubated due  
to hypoxic respiratory failure. He eventually required renal replacement 
therapy, and had a protracted course including acalculous cholecystitis 
necessitating percutaneous cholecystectomy, abdominal wall cellulitis, 
septic shock, and critical care myopathy. The patient eventually 
underwent a tracheostomy and PEG tube placement before being 
discharged to rehab five weeks after admission. He spent seven 
additional weeks in rehab before being discharged home.
DISCUSSION
Although considered a child­
hood disease, MCD should be 
considered in adult patients 
with nephrotic syndrome even 
without a history of childhood 
disease. When MCD flares be­
come severe, close monitoring 
is necessary as it can cause 
 immediate life­threatening 
 complications. When patients 
are not responsive or are un­
able to wean off of steroids as 
is this patient, other means of 
treatment should be pursued  
to reduce the risk of relapse. 
 Currently, there is a paucity  
of clinical data on rates of 
 remission for patients on 
 ritu ximab and for how long 
 remission lasts.
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Figure 1: Microscopic view of Minimal Change Disease
